Associate Physician, Director of Connective Tissue Disease Clinics Brigham & Women's Hospital Harvard Medical School Boston, Massachusetts
Systemic sclerosis (SSc) is a connective tissue disease causing progressive fibrosis of the skin and internal organs. Treating cutaneous symptoms can be difficult and is often dictated by extracutaneous manifestations. In this informative session, learn about the evidence-based recommendations that can help you choose the most appropriate therapy for patients with SSc.
Learning Objectives:
Review clinical presentation of systemic sclerosis (SSc) and its mimickers
Establish mycophenolate mofetil as a first-line treatment for SSc
Learn procedural interventions for Raynaud’s and microstomia